Latest Breaking News On - Sir michael rawlins - Page 1 : comparemela.com
Tributes to North East Professor Sir Michael Rawlins who fought to protect patients from medicine side-effects
chroniclelive.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chroniclelive.co.uk Daily Mail and Mail on Sunday newspapers.
Newcastle s haemophiliacs should have been told they were at clear and special risk of AIDS, inquiry hears
chroniclelive.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chroniclelive.co.uk Daily Mail and Mail on Sunday newspapers.
Nazi Healthcare Revived Across the Five Eyes: Killing Useless Eaters and Biden’s COVID Relief Bill
“The ill-conceived `love of thy neighbor’ has to disappear, especially in relation to inferior or asocial creatures. It is the supreme duty of a national state to grant life and livelihood only to the healthy and hereditarily sound portion of the people in order to secure the maintenance of a hereditarily sound and racially pure folk for all eternity….”
-Dr. Arthur Guett, Nazi Director of Public Health, 1935
The words spoken by Dr. Guett 85 years ago should send shivers down the spine of anyone following the radical transformations of healthcare policy now underway within the Five Eyes zone of influence.
A new orbit
There are big constraints on divergence, but opportunities too
I
N JANUARY 2017 the Conservative Party’s civil war over how to leave the European Union was just beginning. Many Tory
MPs had only a fuzzy idea of what quitting the single market and customs union would mean; some entertained themselves with a campaign to relaunch the Royal Yacht. Sir Michael Rawlins, then the head of the Medicines and Healthcare products Regulatory Agency, (
MHRA) Britain’s drugs regulator, saw the road ahead clearly.
Listen to this story
Enjoy more audio and podcasts oniOSorAndroid.
Leaving the
EU’s pharmaceutical regime, Sir Michael told a House of Lords committee, could mean that Britain was at the “back of the queue” for new treatments as drugmakers neglected Britain’s small market. The European Medicines Agency (